A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
Mathilde Hunault(Centre National de la Recherche Scientifique), Hervé Dombret(University of London Institute in Paris), Caroline Bonmati, Pascal Turlure(Centre Hospitalier Universitaire de Limoges), Patrice Chevallier(Hotel Dieu Hospital), Norbert Ifrah(Institut National du Cancer), Mårina Lafage‐Pochitaloff(Inserm), Philippe Rousselot(Université Paris-Saclay), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Laurence Legros(Hôpital l'Archet), Xavier Thomas(Hôpital Lyon Sud), Martine Escoffre‐Barbe(Université Rennes 2), Nathalie Dhédin(Délégation Paris 5), Frédéric Garban(Hôpital Albert Michallon), O. Legrand, Fabrice Larosa, André Delannoy(Hôpital Saint-Jacques), Oumédaly Reman(Centre Hospitalier Universitaire de Caen), T. Leguay(Hôpital Necker-Enfants Malades), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse)
Cited by 81
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k